Nilotinib-Associated Vascular Events
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference16 articles.
1. Urea derivatives of STI571 as inhibitors of bcr-abl and PDGFR kinases;Manley;Bioorg Med Chem Lett,2004
2. Characterization of AMN107, a selective inhibitor of native and mutant bcr-abl;Weisberg;Cancer Cell,2005
3. Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results;Kantarjian;Blood,2011
4. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia;Saglio;N Engl J Med,2010
5. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial;Kantarjian;Lancet Oncol,2011
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors;Blood;2024-03-07
2. Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary;Pathology and Oncology Research;2024-02-20
3. Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro;Hämostaseologie;2023-01-24
4. Haematological Drugs Affecting Lipid Metabolism and Vascular Health;Biomedicines;2022-08-10
5. Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia;Leukemia & Lymphoma;2022-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3